John T Kao, MD
Orthopedic Surgery · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 15
- 2 carriers
- Office
- 1
On the public record
- Owns SOAR Surgery Center: Accreditation Lapsed
Offices
1 location · Golden State Orthopedics and Spine · 186 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
15 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kao’s office at (408) 293-7767 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G64661 · Current
Licensed to practise in California · since 1988 · expires 2028-11-30 · Howard University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- SOAR Surgery CenterBurlingame, CA12.5% owner since 2010 · accredited by IMQAccreditation Lapsed1 inspection · last 2011-05-06
- SOAR Surgery Center, LLCAmbulatory Surgery Center · Burlingame, CA11.1% owner · accredited by AAAHCAccreditation RenewedNo inspections published
- SOAR Surgery Center, LLCAmbulatory Surgery Center · Burlingame, CA14% owner since 2012 · accredited by AAAASFAccreditation Renewed4 inspections, 4 with deficiencies · last 2017-04-19: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$48,637
Medicare paid this office $48,637 for 148 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 79 | $11,571 | $116 |
| Short return visit (20+ min) | 59 | $6,212 | $84 |
| Aspiration and/or injection of fluid from large joint | 49 | $5,122 | $67 |
| New patient visit (45+ min) | 32 | $4,791 | $150 |
| New patient visit (30+ min) | 24 | $1,802 | $75 |
See all 6 services
| Return visit (30+ min) | 79 | $11,571 | $116 |
| Short return visit (20+ min) | 59 | $6,212 | $84 |
| Aspiration and/or injection of fluid from large joint | 49 | $5,122 | $67 |
| New patient visit (45+ min) | 32 | $4,791 | $150 |
| New patient visit (30+ min) | 24 | $1,802 | $75 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $228 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
148 Original Medicare patients in 2024. Average age 73 · Women 64% · Health risk score 0.75. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 53% · Coronary heart disease 20% · Diabetes 16% · Cancer 11% · Atrial fibrillation 11% · Depression 9% · Heart failure 8% · Chronic kidney disease 8%.
The office billed $212,864, Medicare allowed $64,560 and paid $48,637; for 6,700 services of 26 kinds; $2,634 of it was for drugs given in the office and $46,003 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 148 | 6,700 | 73 | 0.75 | $212,864 | $48,637 |
| 2023 | 144 | 3,906 | 73 | 0.66 | $177,106 | $44,586 |
| 2022 | 162 | 5,792 | 73 | 0.68 | $232,594 | $62,866 |
| 2021 | 172 | 8,157 | 73 | 0.78 | $170,289 | $66,075 |
| 2020 | 149 | 6,959 | 72 | 0.79 | $185,202 | $66,355 |
| 2019 | 187 | 681 | 71 | 0.70 | $188,299 | $68,421 |
| 2018 | 179 | 788 | 72 | 0.75 | $252,326 | $56,785 |
| 2017 | 217 | 1,102 | 73 | 0.88 | $337,247 | $69,325 |
| 2016 | 204 | 997 | 72 | 0.81 | $314,223 | $70,625 |
| 2015 | 160 | 767 | 71 | 0.77 | $264,810 | $61,939 |
| 2014 | 157 | 560 | 70 | 0.75 | $218,674 | $49,191 |
| 2013 | 153 | 723 | 70 | 0.74 | $210,296 | $52,029 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 69 | $10,659 | $113 |
| Short return visit (20+ min) | 59 | $7,101 | $85 |
| Aspiration and/or injection of fluid from large joint | 45 | $4,152 | $58 |
| New patient visit (45+ min) | 24 | $3,622 | $151 |
| New patient visit (30+ min) | 32 | $2,883 | $90 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $198 | None |
2022: 6 services
| Return visit (30+ min) | 83 | $12,875 | $123 |
| Short return visit (20+ min) | 53 | $6,704 | $88 |
| New patient visit (45+ min) | 35 | $5,584 | $160 |
| Aspiration and/or injection of fluid from large joint | 47 | $5,117 | $66 |
| New patient visit (30+ min) | 34 | $3,200 | $94 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $259 | None |
2021: 7 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 11 | $12,771 | None |
| Short return visit (20+ min) | 78 | $10,384 | $85 |
| Return visit (30+ min) | 65 | $8,922 | $110 |
| Aspiration and/or injection of fluid from large joint | 51 | $5,973 | $60 |
| New patient visit (45+ min) | 37 | $5,137 | $139 |
| New patient visit (30+ min) | 50 | $4,950 | $99 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $312 | None |
2020: 7 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 11 | $10,948 | None |
| Short return visit (20+ min) | 83 | $7,674 | $63 |
| Return visit (30+ min) | 56 | $6,775 | $88 |
| Aspiration and/or injection of fluid from large joint | 60 | $5,960 | $54 |
| New patient visit (30+ min) | 38 | $3,095 | $81 |
| New patient visit (45+ min) | 22 | $2,984 | $136 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $277 | None |
2019: 8 services
| Short return visit (20+ min) | 108 | $12,041 | $64 |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 11 | $11,811 | None |
| Return visit (30+ min) | 72 | $8,704 | $101 |
| Aspiration and/or injection of fluid from large joint | 78 | $5,783 | $54 |
| New patient visit (30+ min) | 53 | $4,608 | $87 |
| New patient visit (45+ min) | 28 | $4,041 | $144 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 65 | $108 | None |
| Injection, methylprednisolone acetate, 40 mg | 12 | $66 | None |
2018: 9 services
| Short return visit (20+ min) | 104 | $10,983 | $63 |
| Return visit (30+ min) | 58 | $5,960 | $86 |
| Aspiration and/or injection of fluid from large joint | 64 | $5,730 | $49 |
| New patient visit (30+ min) | 63 | $5,615 | $89 |
| Mri scan of leg joint without contrast | 13 | $2,025 | $145 |
| New patient visit (45+ min) | 14 | $2,011 | $144 |
| Short return visit | 11 | $648 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 40 | $266 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 34 | $250 | None |
2017: 10 services
| Short return visit (20+ min) | 127 | $14,367 | $58 |
| New patient visit (30+ min) | 80 | $6,132 | $77 |
| Aspiration and/or injection of fluid from large joint | 76 | $6,067 | $44 |
| Return visit (30+ min) | 58 | $5,378 | $79 |
| Mri scan of leg joint without contrast | 23 | $4,027 | $161 |
| Short return visit | 14 | $891 | $39 |
| X-ray of hip, 2-3 views | 13 | $662 | $39 |
| X-ray of knee, 3 views | 16 | $615 | $32 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 53 | $353 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 41 | $300 | None |
2016: 10 services
| Short return visit (20+ min) | 116 | $12,803 | $59 |
| Aspiration and/or injection of fluid from large joint | 88 | $7,499 | $48 |
| Return visit (30+ min) | 62 | $6,320 | $82 |
| New patient visit (30+ min) | 70 | $5,408 | $77 |
| Mri scan of leg joint without contrast | 25 | $4,287 | $159 |
| New patient visit (45+ min) | 29 | $3,611 | $125 |
| Mri scan of arm joint without contrast | 16 | $2,919 | $162 |
| Ultrasonic guidance for needle placement | 13 | $950 | $53 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 72 | $477 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $149 | None |
2015: 9 services
| Short return visit (20+ min) | 93 | $10,241 | $61 |
| Aspiration and/or injection of fluid from large joint | 78 | $6,849 | $51 |
| Return visit (30+ min) | 53 | $5,371 | $83 |
| New patient visit (30+ min) | 65 | $5,238 | $81 |
| Mri scan of leg joint without contrast | 24 | $4,065 | $169 |
| New patient visit (45+ min) | 20 | $2,462 | $123 |
| Ultrasonic guidance for needle placement | 12 | $786 | $56 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 79 | $605 | None |
| X-ray of ribs of one side of body, minimum of 2 views | 11 | $384 | $32 |
2014: 8 services
| Short return visit (20+ min) | 83 | $7,068 | $57 |
| Return visit (30+ min) | 47 | $4,741 | $83 |
| New patient visit (30+ min) | 55 | $4,616 | $84 |
| Aspiration and/or injection of fluid from large joint | 55 | $4,109 | $51 |
| Mri scan of leg joint without contrast | 18 | $4,052 | $193 |
| New patient visit (45+ min) | 18 | $2,684 | $149 |
| Ultrasonic guidance for needle placement | 13 | $1,058 | $71 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 55 | $359 | None |
2013: 7 services
| Short return visit (20+ min) | 86 | $9,808 | $61 |
| Aspiration and/or injection of fluid from large joint | 56 | $4,526 | $50 |
| New patient visit (30+ min) | 47 | $4,392 | $93 |
| Return visit (30+ min) | 38 | $3,729 | $91 |
| Mri scan of leg joint without contrast | 14 | $3,115 | $222 |
| New patient visit (45+ min) | 16 | $2,340 | $146 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 52 | $308 | None |
Drugs they prescribed that Part D paid
$8,683
Pharmacies billed $8,683 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 12% of their Part D prescriptions (16 of 133) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
122 generic and 11 brand-name prescriptions · $8,683 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 47 | $1,682 | $36 |
| Diclofenac | 13 | $259 | $20 |
| Meloxicam | 17 | $58 | $3 |
| Prednisone | 13 | $24 | $2 |
Year by year
| 2024 | 133 | 47 | 12% (16) | 8% | $8,683 |
| 2023 | 131 | 53 | 15% (20) | None | $5,939 |
| 2022 | 155 | 58 | 17% (26) | None | $10,536 |
| 2021 | 165 | 66 | 18% (29) | None | $6,378 |
| 2020 | 171 | 57 | 15% (25) | 14% | $15,532 |
| 2019 | 190 | 81 | 21% (39) | 7% | $12,170 |
| 2018 | 243 | 82 | 10% (25) | 10% | $17,018 |
| 2017 | 207 | 70 | 15% (30) | 12% | $18,179 |
| 2016 | 224 | 81 | 14% (31) | 14% | $10,834 |
| 2015 | 154 | 65 | 20% (30) | 12% | $5,430 |
| 2014 | 300 | 47 | 5% (16) | 35% | $34,639 |
| 2013 | 504 | 60 | 4% (20) | None | $53,142 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Celecoxib | 42 | $795 | $19 |
| Diclofenac | 22 | $276 | $13 |
| Prednisone | 14 | $29 | $2 |
2022: 5 drugs
| Celecoxib | 45 | $1,329 | $30 |
| Oxycodone-Acetaminophen | 13 | $191 | $15 |
| Diclofenac | 11 | $167 | $15 |
| Hydrocodone-Acetaminophen | 11 | $84 | $8 |
| Prednisone | 11 | $33 | $3 |
2021: 5 drugs
| Celecoxib | 38 | $1,389 | $37 |
| Diclofenac | 17 | $300 | $18 |
| Oxycodone-Acetaminophen | 15 | $221 | $15 |
| Prednisone | 28 | $112 | $4 |
| Meloxicam | 21 | $47 | $2 |
2020: 6 drugs
| Entresto | 11 | $6,335 | $576 |
| Celecoxib | 53 | $1,640 | $31 |
| Diclofenac | 21 | $405 | $19 |
| Oxycodone-Acetaminophen | 15 | $124 | $8 |
| Prednisone | 14 | $44 | $3 |
| Cephalexin | 11 | $21 | $2 |
2019: 7 drugs
| Celecoxib | 35 | $1,273 | $36 |
| Diclofenac | 33 | $896 | $27 |
| Hydrocodone-Acetaminophen | 21 | $218 | $10 |
| Oxycodone-Acetaminophen | 14 | $118 | $8 |
| Prednisone | 15 | $65 | $4 |
| Meloxicam | 13 | $57 | $4 |
| Cephalexin | 14 | $46 | $3 |
2018: 8 drugs
| Celecoxib | 63 | $3,118 | $49 |
| Diclofenac | 24 | $539 | $22 |
| Hydrocodone-Acetaminophen | 11 | $129 | $12 |
| Oxycodone-Acetaminophen | 11 | $107 | $10 |
| Prednisone | 17 | $70 | $4 |
| Clopidogrel | 11 | $63 | $6 |
| Meloxicam | 18 | $62 | $3 |
| Cephalexin | 11 | $56 | $5 |
2017: 6 drugs
| Celecoxib | 22 | $1,152 | $52 |
| Oxycodone-Acetaminophen | 15 | $145 | $10 |
| Hydrocodone-Acetaminophen | 13 | $141 | $11 |
| Prednisone | 13 | $57 | $4 |
| Meloxicam | 15 | $53 | $4 |
| Cephalexin | 11 | $36 | $3 |
2016: 11 drugs
| Eliquis | 11 | $6,264 | $569 |
| Celecoxib | 32 | $1,720 | $54 |
| Oxycodone-Acetaminophen | 16 | $313 | $20 |
| Nabumetone | 12 | $211 | $18 |
| Hydrocodone-Acetaminophen | 13 | $192 | $15 |
| Warfarin | 13 | $136 | $10 |
| Prednisone | 17 | $73 | $4 |
| Amlodipine Besylate | 11 | $72 | $7 |
| Meloxicam | 12 | $40 | $3 |
| Cephalexin | 11 | $39 | $4 |
| Furosemide | 12 | $24 | $2 |
2015: 5 drugs
| Celecoxib | 11 | $778 | $71 |
| Oxycodone-Acetaminophen | 14 | $286 | $20 |
| Klor-Con M20 | 14 | $218 | $16 |
| Prednisone | 18 | $74 | $4 |
| Cephalexin | 12 | $55 | $5 |
2014: 9 drugs
| Abilify | 23 | $9,156 | $398 |
| Renvela | 27 | $7,040 | $261 |
| Celebrex | 15 | $4,510 | $301 |
| Cyclosporine Modified | 13 | $1,198 | $92 |
| Mycophenolate Mofetil | 13 | $998 | $77 |
| Mirtazapine | 13 | $307 | $24 |
| Clopidogrel | 16 | $195 | $12 |
| Fenofibrate | 11 | $141 | $13 |
| Furosemide | 18 | $107 | $6 |
2013: 17 drugs
| Sensipar | 24 | $15,660 | $652 |
| Renvela | 44 | $9,820 | $223 |
| Abilify | 20 | $7,948 | $397 |
| Celebrex | 20 | $4,543 | $227 |
| Lantus | 13 | $2,189 | $168 |
| Levetiracetam | 23 | $1,358 | $59 |
| Midodrine | 11 | $1,267 | $115 |
| Cyclosporine Modified | 12 | $1,224 | $102 |
| Mycophenolate Mofetil | 11 | $863 | $78 |
| Atorvastatin | 14 | $587 | $42 |
| Mirtazapine | 12 | $369 | $31 |
| Phenytoin Sodium Extended | 13 | $283 | $22 |
| Clopidogrel | 13 | $272 | $21 |
| Furosemide | 41 | $259 | $6 |
| Metoprolol | 16 | $158 | $10 |
| Fenofibrate | 12 | $155 | $13 |
| Gemfibrozil | 11 | $137 | $12 |
Money from drug and device companies
$17 in 2025
| 2025 | 1 | 1 | None | $17 |
| 2024 | 1 | 5 | None | $85 |
| 2023 | 1 | 8 | None | $140 |
| 2022 | 2 | 6 | None | $124 |
| 2021 | 3 | 6 | None | $273 |
| 2020 | 3 | 4 | None | $173 |
| 2019 | 8 | 8 | None | $521 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Rybelsus | $17 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-03-11 | Rybelsus | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $85
| Pfizer | Eliquis | $85 | 5 payments
|
2023: $140
| Pfizer | Eliquis | $140 | 8 payments
|
2022: $124
| Pfizer | Eliquis | $106 | 5 payments
|
| Medtronic | Venaseal | $18 | 1 payment
|
2021: $273
| Tissuetech | Neox | $185 | 1 payment
|
| Pfizer | Eliquis | $72 | 4 payments
|
| Ethicon US | Stratafix | $16 | 1 payment
|
2020: $173
| Zimmer Biomet Holdings | Accufill | $124 | 1 payment
|
| Pfizer | Chantix | $32 | 2 payments
|
| Ferring Pharmaceuticals | Cimzia | $17 | 1 payment
|
2019: $521
| Zimmer Biomet Holdings | Accufill | $134 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $125 | 1 payment
|
| Smith+Nephew | Regeneten | $121 | 1 payment
|
| Akcea Therapeutics | Tegsedi | $71 | 1 payment
|
| Pfizer | None | $22 | 1 payment
|
| Bioventus | Durolane | $19 | 1 payment
|
| Abbott Laboratories | Mitra Clip System | $18 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $12 | 1 payment
|
Professional record
- NPI
- 1790840858
- Licence
- CA G64661California G64661: Current · expires 2028-11-30
- Trained
- Howard University College of Medicine, 1987
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 900 Lafayette St Ste 105, Santa Clara, CA, 95050
- NPI first listed
- 2006-12-27
- NPI last updated
- 2019-07-23
This is when the NPI record was last certified, not a medical board exam.